Nystatin 100000 UNT/ML Oral Suspension — RxCUI 312055
RxNorm drug concept · Semantic clinical drug
RxCUI 312055
Semantic clinical drug · SCD
● Current RxNorm concept 25 FDA products
48 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI312055
Official nameNystatin 100000 UNT/ML Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asnystatin 100,000 UNT/ML Oral Suspension; nystatin 500,000 UNT per 5 ML Oral Suspension
FDA products mapped25
Package NDCs mapped48
Reported Medicaid activity (SDUD)472,281 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Nystatin Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Nystatin topical treats fungal skin infections caused by Candida — the same group of fungi responsible for yeast infections. These infections can appear in warm, moist areas of the...
- What kind of infection does nystatin cream or powder actually treat?
- For Candida foot infections, dust Nyamyc powder directly on your feet — and don't forget to also dust it inside your shoes and socks. For other skin areas, apply the powder to the...
- How do I use the powder correctly, especially for a foot infection?
🕸️ Concept Web — How Nystatin 100000 UNT/ML Oral Suspension Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Nystatin 100000 UNT/ML Oral Suspension
RxCUI 312055 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Nystatin
7597IN
-
Nystatin
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Nystatin Oral Suspension
373136SCDF -
Nystatin Oral Liquid Product
1160433SCDG -
Nystatin Oral Product
1160434SCDG -
Oral Suspension
316969DF -
Oral Liquid Product
1151137DFG -
Oral Product
1151131DFG
-
Nystatin Oral Suspension
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Nystatin 100000 UNT/ML
316395SCDC
-
Nystatin 100000 UNT/ML
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Nystatin 100000 UNT/ML
SCDC · 316395 -
Nystatin Oral Suspension
SCDF · 373136 -
Nystatin Oral Liquid Product
SCDG · 1160433 -
Nystatin Oral Product
SCDG · 1160434
📦 FDA Products & Package NDCs
25 products · 48 package NDCs
48 package NDCs map to RxCUI 312055 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00116-4026-11 | 10 TRAY in 1 CASE (0116-4026-11) / 10 CUP, UNIT-DOSE in 1 T... | Nystatin Oral Suspension | Xttrium Laboratories, Inc. | 2026-02-06 |
| 00116-4026-16 | 473 mL in 1 BOTTLE, PLASTIC (0116-4026-16) | Nystatin Oral Suspension | Xttrium Laboratories, Inc. | 2026-02-09 |
| 00116-4026-50 | 5 TRAY in 1 CASE (0116-4026-50) / 10 CUP, UNIT-DOSE in 1 TR... | Nystatin Oral Suspension | Xttrium Laboratories, Inc. | 2026-02-09 |
| 00121-0810-02 | 60 mL in 1 BOTTLE, DROPPER (0121-0810-02) | Nystatin | Pharmaceutical Associates, Inc. | 2016-02-01 |
| 00121-0810-16 | 473 mL in 1 BOTTLE (0121-0810-16) | Nystatin | Pharmaceutical Associates, Inc. | 2016-02-01 |
| 00121-0868-00 | 10 TRAY in 1 CASE (0121-0868-00) / 10 CUP, UNIT-DOSE in 1 T... | Nystatin | PAI Holdings, LLC dba PAI Pharma | 2020-07-17 |
| 00121-0868-02 | 60 mL in 1 BOTTLE, DROPPER (0121-0868-02) | Nystatin | PAI Holdings, LLC dba PAI Pharma | 2020-07-17 |
| 00121-0868-16 | 473 mL in 1 BOTTLE (0121-0868-16) | Nystatin | PAI Holdings, LLC dba PAI Pharma | 2020-07-17 |
| 00121-0868-50 | 5 TRAY in 1 CASE (0121-0868-50) / 10 CUP, UNIT-DOSE in 1 TR... | Nystatin | PAI Holdings, LLC dba PAI Pharma | 2020-07-17 |
| 00121-1045-16 | 473 mL in 1 BOTTLE (0121-1045-16) | Nystatin | PAI Holdings, LLC dba PAI Pharma | 2024-06-21 |
| 00121-4810-00 | 10 TRAY in 1 CASE (0121-4810-00) / 10 CUP, UNIT-DOSE in 1 T... | Nystatin | Pharmaceutical Associates, Inc. | 2016-02-01 |
| 00121-4810-40 | 4 TRAY in 1 CASE (0121-4810-40) / 10 CUP, UNIT-DOSE in 1 TR... | Nystatin | Pharmaceutical Associates, Inc. | 2016-02-01 |
| 00121-4810-50 | 5 PACKAGE in 1 CASE (0121-4810-50) / 10 CUP, UNIT-DOSE in 1... | Nystatin | Pharmaceutical Associates, Inc. | 2020-06-26 |
| 00904-7276-70 | 10 TRAY in 1 CASE (0904-7276-70) / 10 CUP, UNIT-DOSE in 1 T... | Nystatin | Major Pharmaceuticals | 2022-11-28 |
| 00904-7276-92 | 5 TRAY in 1 CASE (0904-7276-92) / 10 CUP, UNIT-DOSE in 1 TR... | Nystatin | Major Pharmaceuticals | 2022-11-28 |
| 17856-0508-01 | 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-0508-1) / 5 mL... | NYSTATIN | ATLANTIC BIOLOGICALS CORP. | 2024-07-15 |
| 17856-0508-03 | 48 SYRINGE in 1 BOX, UNIT-DOSE (17856-0508-3) / 5 mL in 1 S... | NYSTATIN | ATLANTIC BIOLOGICALS CORP. | 2024-07-17 |
| 17856-0508-05 | 48 SYRINGE in 1 BOX, UNIT-DOSE (17856-0508-5) / 5 mL in 1 S... | NYSTATIN | ATLANTIC BIOLOGICALS CORP. | 2024-07-17 |
| 17856-0508-07 | 120 SYRINGE in 1 BOX, UNIT-DOSE (17856-0508-7) / 1 mL in 1... | NYSTATIN | ATLANTIC BIOLOGICALS CORP. | 2024-07-17 |
| 17856-1045-01 | 72 CUP, UNIT-DOSE in 1 BOX, UNIT-DOSE (17856-1045-1) / 5 mL... | Nystatin | ATLANTIC BIOLOGICALS CORP. | 2024-07-18 |
| 17856-1045-03 | 48 SYRINGE in 1 BOX, UNIT-DOSE (17856-1045-3) / 5 mL in 1 S... | Nystatin | ATLANTIC BIOLOGICALS CORP. | 2024-07-18 |
| 17856-1045-05 | 48 SYRINGE in 1 BOX, UNIT-DOSE (17856-1045-5) / 5 mL in 1 S... | Nystatin | ATLANTIC BIOLOGICALS CORP. | 2024-07-18 |
| 17856-1045-07 | 120 SYRINGE in 1 BOX, UNIT-DOSE (17856-1045-7) / 1 mL in 1... | Nystatin | ATLANTIC BIOLOGICALS CORP. | 2024-07-18 |
| 17856-1045-09 | 1 SYRINGE in 1 BAG (17856-1045-9) / 5 mL in 1 SYRINGE | Nystatin | ATLANTIC BIOLOGICALS CORP. | 2024-07-18 |
| 50090-1740-00 | 60 mL in 1 BOTTLE, GLASS (50090-1740-0) | Nystatin | A-S Medication Solutions | 2015-03-12 |
| 50090-5315-00 | 60 mL in 1 BOTTLE, DROPPER (50090-5315-0) | Nystatin | A-S Medication Solutions | 2020-10-29 |
| 51672-4117-00 | 3785 mL in 1 BOTTLE (51672-4117-0) | Nystatin | Taro Pharmaceuticals U.S.A., Inc. | 1988-02-29 |
| 51672-4117-04 | 1 BOTTLE, DROPPER in 1 CARTON (51672-4117-4) / 60 mL in 1 B... | Nystatin | Taro Pharmaceuticals U.S.A., Inc. | 1988-02-29 |
| 51672-4117-09 | 473 mL in 1 BOTTLE (51672-4117-9) | Nystatin | Taro Pharmaceuticals U.S.A., Inc. | 1988-02-29 |
| 55154-4314-05 | 5 CUP, UNIT-DOSE in 1 BAG (55154-4314-5) / 5 mL in 1 CUP, U... | Nystatin | Cardinal Health 107, LLC | 2023-08-01 |
| 55154-5788-05 | 5 CUP, UNIT-DOSE in 1 BAG (55154-5788-5) / 5 mL in 1 CUP, U... | Nystatin | Cardinal Health 107, LLC | 2020-07-17 |
| 60687-0800-17 | 10 TRAY in 1 CASE (60687-800-17) / 10 CUP, UNIT-DOSE in 1 T... | Nystatin | American Health Packaging | 2024-02-26 |
| 62135-0813-46 | 60 mL in 1 BOTTLE (62135-813-46) | Nystatin | Chartwell RX, LLC | 2024-06-27 |
| 62135-0813-47 | 473 mL in 1 BOTTLE (62135-813-47) | Nystatin | Chartwell RX, LLC | 2024-04-10 |
| 63629-8520-01 | 473 mL in 1 BOTTLE (63629-8520-1) | NYSTATIN | Bryant Ranch Prepack | 2021-05-19 |
| 64950-0372-06 | 60 mL in 1 BOTTLE, DROPPER (64950-372-06) | NYSTATIN | Genus Lifesciences Inc. | 2026-05-11 |
| 64950-0372-47 | 473 mL in 1 BOTTLE (64950-372-47) | NYSTATIN | Genus Lifesciences Inc. | 2026-03-24 |
| 68071-3543-06 | 1 BOTTLE in 1 PACKAGE (68071-3543-6) / 60 mL in 1 BOTTLE | NYSTATIN | NuCare Pharmaceuticals,Inc. | 2023-11-29 |
| 68788-8561-04 | 473 mL in 1 BOTTLE (68788-8561-4) | NYSTATIN | Preferred Pharmaceuticals Inc. | 2024-01-08 |
| 68999-0813-24 | 2 TRAY in 1 BOX (68999-813-24) / 10 CUP in 1 TRAY / 5 mL in... | Nystatin | Chartwell Governmental & Specialty RX, LLC | 2025-11-07 |
| 69315-0504-47 | 473 mL in 1 BOTTLE (69315-504-47) | NYSTATIN | Leading Pharma, LLC | 2022-12-05 |
| 69315-0504-60 | 1 BOTTLE in 1 PACKAGE (69315-504-60) / 60 mL in 1 BOTTLE | NYSTATIN | Leading Pharma, LLC | 2022-12-05 |
| 72162-2645-02 | 473 mL in 1 BOTTLE (72162-2645-2) | NYSTATIN | Bryant Ranch Prepack | 2026-05-11 |
| 72162-2645-06 | 1 BOTTLE in 1 CARTON (72162-2645-6) / 60 mL in 1 BOTTLE | NYSTATIN | Bryant Ranch Prepack | 2026-05-11 |
| 81033-0015-01 | 100 CUP, UNIT-DOSE in 1 CASE (81033-015-01) / 5 mL in 1 CUP... | NYSTATIN | Kesin Pharma Corporation | 2025-11-24 |
| 81033-0015-16 | 473 mL in 1 BOTTLE (81033-015-16) | NYSTATIN | Kesin Pharma Corporation | 2026-06-30 |
| 81033-0015-54 | 50 CUP, UNIT-DOSE in 1 CARTON (81033-015-54) / 5 mL in 1 CU... | NYSTATIN | Kesin Pharma Corporation | 2025-11-24 |
| 85742-0013-11 | 473 mL in 1 BOTTLE (85742-013-11) | NYSTATIN | Kanchan Healthcare Inc | 2025-09-12 |
Observed labelers:
ATLANTIC BIOLOGICALS CORP. (9) ·
PAI Holdings, LLC dba PAI Pharma (5) ·
Pharmaceutical Associates, Inc. (5) ·
Bryant Ranch Prepack (3) ·
Kesin Pharma Corporation (3) ·
Taro Pharmaceuticals U.S.A., Inc. (3)
· +12 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.